Bicara Therapeutics Inc. (BCAX)
BCAX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$17.34
+0.06% on the day
Market cap
$1.1B
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | BCAX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0002023658 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-02-26 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-08-25 |
| Latest proxy | DEFA14A | 2026-04-27 |
Source: SEC EDGAR submissions feed, 262 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +5.6% |
| 1 month | -23.5% |
| 3 months | -37.2% |
| Year to date | +3.1% |
| 1 year | -6.3% |
| From 52-week high | -42.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DMRA | Damora Therapeutics Inc. | $18.56 | -8.37% | $1.1B |
| TRAX | First Tracks Biotherapeutics Inc. Ordinary Shares | $31.68 | -6.96% | $1.1B |
| ORIC | Oric Pharmaceuticals Inc. | $11.31 | -4.23% | $1.2B |
| LBRX | LB Pharmaceuticals Inc | $34.79 | -3.17% | $1.1B |
| AMPH | Amphastar Pharmaceuticals Inc. | $26.05 | -2.65% | $1.1B |
| NBTX | Nanobiotix S.A. | $21.49 | -8.16% | $1.1B |
| KARD | Kardigan Inc. | $12.97 | -9.62% | $1.2B |
| HROW | Harrow Inc. | $28.24 | -2.99% | $1.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier